FLSM
AUTL
Frazier Life Sciences Management’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Hold |
4,623,324
| – | – | 0.42% | 39 |
|
|
2025
Q1 | $7.17M | Hold |
4,623,324
| – | – | 0.33% | 37 |
|
|
2024
Q4 | $10.9M | Hold |
4,623,324
| – | – | 0.45% | 35 |
|
|
2024
Q3 | $16.8M | Hold |
4,623,324
| – | – | 0.67% | 32 |
|
|
2024
Q2 | $16.1M | Hold |
4,623,324
| – | – | 0.75% | 29 |
|
|
2024
Q1 | $29.5M | Buy |
4,623,324
+876,467
| +23% | +$5.59M | 1.24% | 25 |
|
|
2023
Q4 | $24.1M | Hold |
3,746,857
| – | – | 1.29% | 21 |
|
|
2023
Q3 | $8.73M | Hold |
3,746,857
| – | – | 0.58% | 31 |
|
|
2023
Q2 | $8.92M | Hold |
3,746,857
| – | – | 0.53% | 34 |
|
|
2023
Q1 | $6.89M | Hold |
3,746,857
| – | – | 0.5% | 37 |
|
|
2022
Q4 | $7.12M | Hold |
3,746,857
| – | – | 0.44% | 35 |
|
|
2022
Q3 | $8.02M | Hold |
3,746,857
| – | – | 0.62% | 34 |
|
|
2022
Q2 | $10.6M | Hold |
3,746,857
| – | – | 1% | 26 |
|
|
2022
Q1 | $15.6M | Buy |
+3,746,857
| New | +$15.6M | 1.33% | 24 |
|